News Archives - Page 3 of 3 - Prozomix

Prozomix has obtained a further MRes research grant (“Investigation into the Potential of Whole Organism Recombinant Polysaccharide Degradomes when Applied to Biomass Conversion”) from ONE (One North East).

Further rapid / essential growth of the global renewable energy sector is dependent heavily on the development of new technologies.  In particular, greatly improved access to the huge natural diversity of enzymes evolved to degrade plant cell wall material especially offers hope with respect to the emerging biofuel / biorefinery programmes.  However, tapping into this diversity requires a committed step approach to how such products are developed and made available to the global research community.

Prozomix is currently engaged with a rapidly expanding R&D programme to deliver such advanced research products, that are fully compatible with current rapid research techniques.  This grant, jointly held with Northumbria University, UK, will attempt to address some of the practical issues relating to efficient biomass saccharification, by developing complete libraries of glycoside hydrolases, lyases, esterases and other activities, from genome sequenced organisms (not yet currently extensively studied from this perspective) possessing especially large repertoirs of these enzymes, such as Opitutus terrae PB90-1.

Prozomix is pleased to announce that its rapidly expanding range of recombinant enzymes / proteins is now BLAST searchable.  Prozomix believes in this post-genomic era there is no longer any excuse for enzyme / protein products not being as transparent as possible, to enable the researcher to make the best possible informed purchasing decisions.  To this end, in conjunction with primary sequences of all our research enzymes / proteins being freely available, the Prozomix web site is now also BLAST searchable!

After successfully launching its Commercial Academic Partner (CAP) Programme, Prozomix is now expanding this area of its business by offering to partner with any academic looking to exploit their recombinant enzyme / protein expression clones. Under the terms of the CAP agreement, the academic (their institution) will receive a very generous royalty payment of 17.5% on all sales, with Prozomix being responsible for all aspects (and costs) of the production, preparation and sale of the products.


Prozomix has become UK and Republic of Ireland Distributor for NZYTech molecular biology and research products.  Prozomix is delighted to have signed this exclusive deal with NZYTech (www.NZYTech.com) to distribute their entire product range:


For more information or to request a catalogue for NZYTech products, please enquire.

Prozomix has obtained a 3-year PhD research grant (“The Development of Sequence Divergent Ranges of Biomass Converting Enzymes”) from EPSRC.  Further rapid / essential growth of the global renewable energy sector is dependent heavily on the development of new technologies.  In particular, greatly improved access to the huge natural diversity of enzymes evolved to degrade plant cell wall material especially offers hope with respect to the emerging biofuel / biorefinery programmes.  However, tapping into this diversity requires a committed step approach to how such products are developed and made available to the global research community.  Prozomix is currently engaged with a rapidly expanding R&D programme to deliver such advanced research products, which are fully compatible with current rapid research techniques.  This grant, jointly held with Northumbria University, UK, will focus on the research and development of ranges of enzymes related by defined primary sequence homology, and their use in biomass saccharification research.

Prozomix has obtained an MRes research grant (“Production and Biochemical Characterisation of a New Range of Recombinant Biomass Conversion Enzymes for Biofuel / Biorefinery applications”) from EPSRC.  Further rapid / essential growth of the global renewable energy sector is dependent heavily on the development of new technologies.  In particular, greatly improved access to the huge natural diversity of enzymes evolved to degrade plant cell wall material especially offers hope with respect to the emerging biofuel / biorefinery programmes.  However, tapping into this diversity requires a committed step approach to how such products are developed and made available to the global research community.  Prozomix is currently engaged with a rapidly expanding R&D programme to deliver such advanced research products, which are fully compatible with current rapid research techniques.  This grant, jointly held with Northumbria University, UK, will focus on the applied characterisation of a large range of as yet unstudied enzymes mined from the global microbial genomic resource.

Prozomix is pleased to announce the commencement of a strategic relationship with NEPAF (North East England Proteome Analysis Facility) that will see the development of next generation recombinant proteins for various applications, including the diagnosis and monitoring of human disease. The collaboration with NEPAF (a project of Cels, the Centre of Excellence for Life Sciences) is supported by One North East and the European Regional Development Fund, and will see the development of a range of new standards for quantitative proteomics, based on SILReP™ (Stable Isotope Labelling of Recombinant Proteins) technology.  The project, designed to exploit core competencies of each partner, will progress to the prototype product stage by mid 2009.